> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# ActiPatch Cleared for Musculoskeletal Pain
- URL: https://www.fdaweb.com/actipatch-cleared-for-musculoskeletal-pain/
- Published: 2020-02-05T12:00:00.000Z
- Updated: 2026-09-14T16:01:48.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5146025

FDA has cleared a BioElectronics 510(k) for its over-the counter (OTC) ActiPatch medical device and its expanded indication — *adjunctive treatment of musculoskeletal pain. The device was originally cleared in 2017* for OTC treatment of pain from knee osteoarthritis and plantar fasciitis. The device uses electromagnetic pulse therapy for treating pain, the company says, adding that it is safe for continuous use. Unlike a transcutaneous electrical nerve stimulation device, Actipatch uses no heat or vibrations, it says.